Follow-up of neuropathy from 2',3'-dideoxycytidine.
D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D016047:Zalcitabine
D003841:Deoxycytidine; D016047:Zalcitabine